PBD Biotech

PBD Biotech develops Actiphage, a blood test that detects 'active', disease-causing tuberculosis infection.

[PBD Biotech @PBDBiotech]

Inspirational speakers discussed putting patients at the heart of drug development, new technologies and data driven medicine at the #PrixGalien UK Awards last night; aptly held under Hope, the blue whale. Many thanks to Pr Sir Munir Pirmohamed and everyone involved.

[PBD Biotech @PBDBiotech]

How can you negotiate a successful tech spin-out? Find out in the ‘Setting up to Spin Out’ session at #Climb24 hosted by Jane Theaker @PBDBiotech with Michael Murray, @BioMetallo Sim Singh-Landa @praetura_ven Lizzie Withington @UniofNewcastle https://t.co/SlpJWUlr4y @Bionow

[PBD Biotech @PBDBiotech]

Thanks @myADLM for shortlisting us for Disruptive Tech Award. Actiphage TB, first test to confirm TB disease progression by detecting live bacteria in the blood. Will enable targeting of treatment to those at most risk, an unmet need for #EndTB campaign
https://t.co/5A90vf5V6s

[PBD Biotech @PBDBiotech]

Phage therapy can be the last resort for some patients. We shared our experiences of selecting, purifying and transporting phage with @phagedirectory a community of hero researchers and clinicians who are matching phages with bacterial infections. https://t.co/nok7Cy2Fyf

[PBD Biotech @PBDBiotech]

Well done team. "Gaining ISO 13485 accreditation has required a huge effort and I am so proud of what has been achieved." says CEO Jane Theaker. "It provides assurance that our Actiphage TB Blood test is being developed to the highest standards"
https://t.co/rTMsSMUMCm

[PBD Biotech @PBDBiotech]

@JessicaSacher Thank you Jessica for this opportunity - we are keen to engage with others working in this field and share learnings.

[PBD Biotech @PBDBiotech]

@FCDOGovUK @StopTB Current tests aren't able to break the cycle of infection. In its #WorldTBDay supplement, Int Journal of Infectious Disease highlighed UK's Actiphage as one of the most promising diagnostics in the pipeline. Agreed support for innovation is key #EndTB
https://t.co/zkwirE6SZE

[PBD Biotech @PBDBiotech]

@think_network_x That is impressive - keep up the good work. Highlights also the need for diagnostics that provide a test of cure. Together #YesWeCanEndTB

[PBD Biotech @PBDBiotech]

World TB Day 2024 is a moment to take stock of developments in the fight to end tuberculosis; a treatable, preventable disease that is still the commonest cause of death from an infectious disease. New diagnostics are key
#WorldTBDay2024 #YesWeCanEndTB https://t.co/Wl6ubeNVEf

[PBD Biotech @PBDBiotech]

Interesting study by @LSTMnews shows sensitivity needed when screening household contacts for incipient TB. Highlights the need also for improved non-invasive diagnostics #WorldTBDay24 #YesWeCanEndTB

[LSTM @LSTMnews]

Ahead of #WorldTBDay, a new @Cochrane_IDG review has found that door-to-door TB screening and contact tracing can improve diagnosis rates, but must be paired with effective follow-up care to be successful.

Read more: https://t.co/NNSueSnu4j

[PBD Biotech @PBDBiotech]

Drug-resistant TB accounts for 1 in 3 deaths from AMR so fitting theme for 5th Annual Infectious Disease and Molecular Diagnostics Conference ahead of #WorldTBDay Helen Dent @BIVDA discussing new advances including Actiphage. #WeCanEndTB https://t.co/XXBnZDtzeR

[PBD Biotech @PBDBiotech]

80 percent of people with TB do not have a persistent cough and yet are still infective. Research @amsterdamumc @TheLancetInfDis ahead of #worldtbday2024 highlights urgent need for biomarkers for disease progression to break the cycle of infection #EndTB https://t.co/KDuIy4eyDL

[PBD Biotech @PBDBiotech]

Are phage-based diagnostics the next big thing in the fight against tuberculosis? Article in @pathologistmag by Dr Pranab Haldar @LeicResearch discusses findings of research using Actiphage TB and progress towards @WHO target product profile #EndTB
https://t.co/PWThGoSnQ6

[PBD Biotech @PBDBiotech]

Is ending TB (finally) within sight? New report from @TBAlliance & FIND concludes progress in new tool dev is accelerating. Actiphage aligns with their goals, offering potential for a simpler way to screen individuals at high risk of disease progression
https://t.co/fRUzQy0G6I

[PBD Biotech @PBDBiotech]

Delighted to be finalists for #BioNowAwards Social Impact Award for our work to #EndTB. Proud to be alongside: leading cancer centre @TheChristieNHS, @_HENorth fighting health inequalities and the Afro-Caribbean Commercial Science Network @theACCSN Thanks sponsors @SquareOneLaw

[Bionow @Bionow]

🎉 The #BionowAwards shortlist is NOW LIVE! 🎉 Thank you to all who submitted nominations, the standard was incredible! After much deliberation, our judges have shortlisted the nominees in the link below:

https://t.co/n91PtmbFih

Our fabulous finalists are as follows...

1/15

[PBD Biotech @PBDBiotech]

Drug-resistant Tuberculosis accounts for 1 in 3 deaths from antimicrobial resistance (AMR)*, meaning grim predictions for a ‘post-antibiotic age’ are already a reality for many. Looking forward to hearing about solutions #BioInfect @bionow @iiconNW @STFC_Matters

[PBD Biotech @PBDBiotech]

Thank you @TB_NewsDaily for sharing. Actiphage is a breakthrough diagnostic that offers hope for better targeted intervention to prevent disease and limit onward transmission, key components of WHO’s #EndTb strategy.

[PBD Biotech @PBDBiotech]

A groundbreaking study for phage-diagnostics, please share @Leicester_Phage @MotherOfPhage @phagedirectory Together we can #EndTB

[PBD Biotech @PBDBiotech]

Study @LancetMicrobe reveals a potential novel biomarker of TB risk in household contacts. It shows significant association between Mtb DNA detected by Actiphage in the blood and progressive tuberculosis infection @LeicResearch @BMCS88 #EndTB https://t.co/iLU6uxFZda

[PBD Biotech @PBDBiotech]

Study @LancetMicrobe reveals a potential novel biomarker of TB risk in household contacts. It shows significant association between Mtb DNA detected by Actiphage in the blood and progressive tuberculosis infection @LeicResearch @BMCS88 #EndTB https://t.co/iLU6uxFZda

[PBD Biotech @PBDBiotech]

Antimicrobial resistance has been declared by the @WHO as one of the top 10 global public health threats. Ben Swift@BMCS88 Ben Swift, a pioneer in phage-based diagnostics, is to present in the 'What's in the Pipeline' session at #BioInfect 2024. @Bionow
https://t.co/v6enp7Oeui